Valuation: Abingdon Health Plc

Market Cap 39.16M 52.46M 46.98M 43.21M 73.19M 4.98B 74.56M 515M 207M 2.62B 197M 193M 8.26B P/E 2027 *
-36x
P/E 2028 * 113x
Enterprise Value 38.26M 51.25M 45.9M 42.22M 71.51M 4.87B 72.85M 503M 202M 2.56B 192M 188M 8.07B EV / Sales 2027 *
3.11x
EV / Sales 2028 * 2.68x
Free-Float
69.57%
Yield 2027 *
-
Yield 2028 * -
1 month-18.18%
3 months-14.29%
6 months+5.88%
Current year+40.62%
1 week 8.5
Extreme 8.5
9.5
1 month 8.5
Extreme 8.5
11.5
Current year 5.5
Extreme 5.5
13
1 year 5.5
Extreme 5.5
13
3 years 5.1
Extreme 5.1
13
5 years 3.6
Extreme 3.6
50.5
10 years 3.6
Extreme 3.6
136.65
Manager TitleAgeSince
Director of Finance/CFO 49 05/01/2025
Chief Tech/Sci/R&D Officer - 31/10/2019
Chief Operating Officer - 31/01/2022
Director TitleAgeSince
Chairman 65 31/12/2014
Director/Board Member 64 25/10/2020
Director/Board Member 49 05/01/2025
Date Insider Type Main position Quantity % Market Cap. Importance
04/12/25 Free 555,000 0.2211%
04/12/25 Free

Chief Financial Officer

660,000 0.2629%
04/12/25 Free

Chief Operating Officer

300,000 0.1195%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+49.50%-12.20% 52.46M
+1.56%+2.41%-14.09%+12.32% 184B
-0.59%+1.18%+6.44%+36.82% 118B
-6.38%-4.98%-18.07%+8.01% 111B
+3.42%+1.71%-41.92%+8.01% 94.58B
+0.09%-0.05%-2.06%+78.69% 63.13B
-0.46%+0.42%+4.48%+82.84% 55.66B
-0.23%-0.52%+10.73%-21.72% 53.9B
-4.30%-1.64%-12.44%+37.99% 43.42B
+0.58%+2.00%-1.17%-8.82% 34.68B
Average -0.63%+0.05%-1.86%+22.19% 75.85B
Weighted average by Cap. -0.48%+0.24%-10.13%+23.75%

Financials

2027 *2028 *
Net sales 12.3M 16.48M 14.76M 13.57M 22.99M 1.56B 23.42M 162M 64.99M 823M 61.84M 60.53M 2.6B 15.15M 20.3M 18.18M 16.72M 28.32M 1.93B 28.85M 199M 80.04M 1.01B 76.17M 74.55M 3.2B
Net income -1.07M -1.44M -1.29M -1.19M -2.01M -137M -2.05M -14.14M -5.67M -71.86M -5.4M -5.28M -227M 360K 482K 432K 397K 673K 45.79M 686K 4.74M 1.9M 24.09M 1.81M 1.77M 75.97M
Net Debt -900K -1.21M -1.08M -993K -1.68M -114M -1.71M -11.85M -4.76M -60.22M -4.52M -4.43M -190M 1.5M 2.01M 1.8M 1.66M 2.8M 191M 2.86M 19.74M 7.93M 100M 7.54M 7.38M 317M
Projected Income Statement - Annual - Abingdon Health Plc
Logo Abingdon Health Plc
Abingdon Health plc is an international lateral flow contract research (CRO) and contract development and manufacturing organization (CDMO). The Company is an international developer, manufacturer and distributor of effective rapid tests. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its CDMO division has the internal capabilities to take lateral flow projects, in areas such as infectious disease and clinical testing, including companion diagnostics, and others. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests. The Abingdon Simply Test’s other selected self-test products, such as the saliva pregnancy test, Salistick, which is sold through international distributors and through other channels in the United Kingdom and Ireland, such as pharmacy chains.
Employees
131
Date Price Change Volume
30/10/26 GBX 9.000 -.--% 55,032
29/10/26 GBX 9.000 -.--% 7,399
28/10/26 GBX 9.000 -.--% 46,884
27/10/26 GBX 9.000 -.--% 6,704
26/10/26 GBX 9.000 -.--% 164,784
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Abingdon Health Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0900GBP
Average target price
0.1900GBP
Spread / Average Target
+111.11%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Abingdon Health Plc
  1. Stock Market
  2. Stocks
  3. ABDX Stock